P1.03-31 BRAF Mutations: Classes I, II and III in NSCLC Patients Included in the SLLIP Trial, Targeted Treatment According to Class

Authors :: Rebecca J. Nagy
Richard B. Lanman
Jillian Wilhelmina Paulina Bracht
Rafael Rosell
Iris Faull
Manuel Fernandez-Bruno
M.A. Molina-Vila
J.J. Garcia Mosquera
A. Aguilar Hernandez
Trever G. Bivona
Niki Karachaliou
Ana Drozdowskyj
Maria Gonzalez-Cao
Jordi Berenguer
Source :: Journal of Thoracic Oncology. 14:S430-S431
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
Internal medicine
medicine
business
Class (biology)

Full Text Access

Tools